Zonova is a UK-based antimicrobial materials company developing embedded antimicrobial technologies for medical devices. Founded in 2023, the company’s proprietary platform integrates antimicrobial protection directly into polymers to prevent microbial colonisation and biofilm formation without relying on antibiotics or toxic leaching compounds. Zonova partners with medical device manufacturers through a scalable licensing model designed to accelerate infection-resistant innovation across global healthcare systems.
Zonova
- Health
- London, United Kingdom
- £2.1m
- zonovatech.com
- Update Information
More venture news
- 26 May 2026

ZonovaZonova lands a £2.1m seed round from THENA Capital to prevent infection in medical devices
SeedHealth - 21 May 2026

TympaHealthTympaHealth secures £2m Innovate UK loan for AI guidance platform supporting community ear and hearing care
Debt financingHealth - 19 May 2026

NEX Health IntelligenceNEX Health Intelligence unlocks a £870k pre-seed round led by Brighteye Ventures for software that predicts the spread of infections in hospitals
Pre-seedHealth
